Self.co
Goelbasi, Ankara, Turkey · Biotechnology, Health Care, hospital & health care · 35 employees
Self.co is a digital health company focused on helping individuals understand and manage allergies and food intolerances through innovative testing solutions. It offers proprietary microarray tests that analyze allergens and food sensitivities using simple blood samples taken at home. By eliminating intermediaries, Self.co provides laboratory-grade testing at a fraction of traditional costs. Their
Funding history
- Series seed — $2.6M — Nov 2025
Recent signals
- Nov 11, 2025: Raised $2.6M in Series seed
See plans & pricing → Track Self.co’s funding, hiring, and signals — with verified contacts — on Fundz.